Logo image of ASGN

ASGN INC (ASGN) Stock Fundamental Analysis

USA - NYSE:ASGN - US00191U1025 - Common Stock

48.27 USD
+0.92 (+1.94%)
Last: 10/1/2025, 8:23:18 PM
48.27 USD
0 (0%)
After Hours: 10/1/2025, 8:23:18 PM
Fundamental Rating

5

Overall ASGN gets a fundamental rating of 5 out of 10. We evaluated ASGN against 87 industry peers in the IT Services industry. ASGN has only an average score on both its financial health and profitability. ASGN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ASGN had positive earnings in the past year.
ASGN had a positive operating cash flow in the past year.
ASGN had positive earnings in each of the past 5 years.
In the past 5 years ASGN always reported a positive cash flow from operatings.
ASGN Yearly Net Income VS EBIT VS OCF VS FCFASGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.77%, ASGN is in the better half of the industry, outperforming 63.22% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.67%, ASGN is in the better half of the industry, outperforming 63.22% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.97%, ASGN is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ASGN is significantly below the industry average of 21.81%.
Industry RankSector Rank
ROA 3.77%
ROE 7.67%
ROIC 5.97%
ROA(3y)6.26%
ROA(5y)7.32%
ROE(3y)11.85%
ROE(5y)14.03%
ROIC(3y)8.44%
ROIC(5y)8.19%
ASGN Yearly ROA, ROE, ROICASGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 3.50%, ASGN perfoms like the industry average, outperforming 58.62% of the companies in the same industry.
ASGN's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.67%, ASGN perfoms like the industry average, outperforming 58.62% of the companies in the same industry.
ASGN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 28.84%, ASGN is doing worse than 63.22% of the companies in the same industry.
ASGN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.67%
PM (TTM) 3.5%
GM 28.84%
OM growth 3Y-5.33%
OM growth 5Y-1.69%
PM growth 3Y-25.23%
PM growth 5Y-3.53%
GM growth 3Y0.44%
GM growth 5Y0.3%
ASGN Yearly Profit, Operating, Gross MarginsASGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASGN is destroying value.
ASGN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ASGN has been reduced compared to 5 years ago.
ASGN has a worse debt/assets ratio than last year.
ASGN Yearly Shares OutstandingASGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASGN Yearly Total Debt VS Total AssetsASGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.56 indicates that ASGN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ASGN has a Altman-Z score (2.56) which is comparable to the rest of the industry.
The Debt to FCF ratio of ASGN is 3.57, which is a good value as it means it would take ASGN, 3.57 years of fcf income to pay off all of its debts.
ASGN has a Debt to FCF ratio of 3.57. This is in the better half of the industry: ASGN outperforms 62.07% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that ASGN is somewhat dependend on debt financing.
ASGN has a Debt to Equity ratio of 0.66. This is comparable to the rest of the industry: ASGN outperforms 41.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.57
Altman-Z 2.56
ROIC/WACC0.67
WACC8.9%
ASGN Yearly LT Debt VS Equity VS FCFASGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.11 indicates that ASGN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.11, ASGN is in the better half of the industry, outperforming 60.92% of the companies in the same industry.
ASGN has a Quick Ratio of 2.11. This indicates that ASGN is financially healthy and has no problem in meeting its short term obligations.
ASGN's Quick ratio of 2.11 is fine compared to the rest of the industry. ASGN outperforms 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ASGN Yearly Current Assets VS Current LiabilitesASGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

ASGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.04%.
ASGN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.16% yearly.
The Revenue has decreased by -6.31% in the past year.
ASGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.72% yearly.
EPS 1Y (TTM)-15.04%
EPS 3Y-2.25%
EPS 5Y2.16%
EPS Q2Q%-13.97%
Revenue 1Y (TTM)-6.31%
Revenue growth 3Y0.74%
Revenue growth 5Y3.72%
Sales Q2Q%-1.36%

3.2 Future

The Earnings Per Share is expected to grow by 4.24% on average over the next years.
Based on estimates for the next years, ASGN will show a small growth in Revenue. The Revenue will grow by 1.63% on average per year.
EPS Next Y-12.54%
EPS Next 2Y-1.08%
EPS Next 3Y4.24%
EPS Next 5YN/A
Revenue Next Year-3.48%
Revenue Next 2Y-0.57%
Revenue Next 3Y1.63%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ASGN Yearly Revenue VS EstimatesASGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
ASGN Yearly EPS VS EstimatesASGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.06, which indicates a very decent valuation of ASGN.
Based on the Price/Earnings ratio, ASGN is valued cheaper than 90.80% of the companies in the same industry.
ASGN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.79.
Based on the Price/Forward Earnings ratio of 9.43, the valuation of ASGN can be described as reasonable.
Based on the Price/Forward Earnings ratio, ASGN is valued cheaper than 91.95% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.21. ASGN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.06
Fwd PE 9.43
ASGN Price Earnings VS Forward Price EarningsASGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

ASGN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ASGN is cheaper than 82.76% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ASGN indicates a rather cheap valuation: ASGN is cheaper than 94.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.23
EV/EBITDA 8.65
ASGN Per share dataASGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.66
EPS Next 2Y-1.08%
EPS Next 3Y4.24%

0

5. Dividend

5.1 Amount

No dividends for ASGN!.
Industry RankSector Rank
Dividend Yield N/A

ASGN INC

NYSE:ASGN (10/1/2025, 8:23:18 PM)

After market: 48.27 0 (0%)

48.27

+0.92 (+1.94%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners98.61%
Inst Owner Change-2.53%
Ins Owners3.59%
Ins Owner Change-0.02%
Market Cap2.11B
Analysts72.31
Price Target58.65 (21.5%)
Short Float %4.75%
Short Ratio3.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.37%
Min EPS beat(2)-5.06%
Max EPS beat(2)5.79%
EPS beat(4)3
Avg EPS beat(4)1.87%
Min EPS beat(4)-5.06%
Max EPS beat(4)5.79%
EPS beat(8)7
Avg EPS beat(8)2.52%
EPS beat(12)8
Avg EPS beat(12)1.43%
EPS beat(16)12
Avg EPS beat(16)3.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.38%
Min Revenue beat(2)-1.31%
Max Revenue beat(2)0.55%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)0.55%
Revenue beat(8)1
Avg Revenue beat(8)-1.6%
Revenue beat(12)1
Avg Revenue beat(12)-1.77%
Revenue beat(16)3
Avg Revenue beat(16)-1.28%
PT rev (1m)0%
PT rev (3m)-5.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.16%
EPS NY rev (1m)0%
EPS NY rev (3m)1.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE 10.06
Fwd PE 9.43
P/S 0.53
P/FCF 6.23
P/OCF 5.6
P/B 1.16
P/tB N/A
EV/EBITDA 8.65
EPS(TTM)4.8
EY9.94%
EPS(NY)5.12
Fwd EY10.6%
FCF(TTM)7.74
FCFY16.04%
OCF(TTM)8.62
OCFY17.86%
SpS91.44
BVpS41.71
TBVpS-18.3
PEG (NY)N/A
PEG (5Y)4.66
Profitability
Industry RankSector Rank
ROA 3.77%
ROE 7.67%
ROCE 8.14%
ROIC 5.97%
ROICexc 6.23%
ROICexgc 38.16%
OM 6.67%
PM (TTM) 3.5%
GM 28.84%
FCFM 8.47%
ROA(3y)6.26%
ROA(5y)7.32%
ROE(3y)11.85%
ROE(5y)14.03%
ROIC(3y)8.44%
ROIC(5y)8.19%
ROICexc(3y)8.85%
ROICexc(5y)8.94%
ROICexgc(3y)45.83%
ROICexgc(5y)47.14%
ROCE(3y)11.51%
ROCE(5y)11.17%
ROICexcg growth 3Y-8.35%
ROICexcg growth 5Y2.66%
ROICexc growth 3Y-8.5%
ROICexc growth 5Y-0.68%
OM growth 3Y-5.33%
OM growth 5Y-1.69%
PM growth 3Y-25.23%
PM growth 5Y-3.53%
GM growth 3Y0.44%
GM growth 5Y0.3%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.57
Debt/EBITDA 3.29
Cap/Depr 37.89%
Cap/Sales 0.96%
Interest Coverage 4.15
Cash Conversion 102.47%
Profit Quality 242.11%
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 2.56
F-Score5
WACC8.9%
ROIC/WACC0.67
Cap/Depr(3y)39.16%
Cap/Depr(5y)38.51%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.87%
Profit Quality(3y)166.38%
Profit Quality(5y)146.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.04%
EPS 3Y-2.25%
EPS 5Y2.16%
EPS Q2Q%-13.97%
EPS Next Y-12.54%
EPS Next 2Y-1.08%
EPS Next 3Y4.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.31%
Revenue growth 3Y0.74%
Revenue growth 5Y3.72%
Sales Q2Q%-1.36%
Revenue Next Year-3.48%
Revenue Next 2Y-0.57%
Revenue Next 3Y1.63%
Revenue Next 5YN/A
EBIT growth 1Y-19.89%
EBIT growth 3Y-4.63%
EBIT growth 5Y1.96%
EBIT Next Year37.71%
EBIT Next 3Y16.33%
EBIT Next 5YN/A
FCF growth 1Y7.89%
FCF growth 3Y31.88%
FCF growth 5Y5.39%
OCF growth 1Y5.98%
OCF growth 3Y27.34%
OCF growth 5Y5.01%